References
- 1. Carnevali A, Cicinelli MV, Capuano V, Corvi F, Mazzaferro A, Querques L, et al. Optical Coherence Tomography Angiography: A Useful Tool for Diagnosis of Treatment-Naïve Quiescent Choroidal Neovascularization // Am J Ophthalmol, 2016; 169:189–98.10.1016/j.ajo.2016.06.042
- 2. Jutley G, Jutley G, Tah V, Lindfield D, Menon G. Treating peripapillary choroidal neovascular membranes: a review of the evidence // Eye (Lond), 2011;25(6):675–68110.1038/eye.2011.24
- 3. Browning DJ, Fraser CM. Ocular conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes // Ophthalmology, 2005; 112:1054-106110.1016/j.ophtha.2004.11.062
- 4. Wilde C, Patel M, Lakshmanan A, Amankwah R, Dhar-Munshi S, Amoaku W. The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography // Eye. 2015;29:602–9.10.1038/eye.2015.44
- 5. Wilde C, Poostchi A, Mehta RL et al. Prevalence of peripapillary choroidal neovascular membranes (PCNV) in an elderly UK population-the Bridlington eye assessment project (BEAP): a cross-sectional study (2002-2006) // Eye (Lond), 2019;33(3):451-458.10.1038/s41433-018-0232-y
- 6. Binder S. Surgical treatment of peripapillary choroidal neovascularization // Br J Ophthalmol. 2007;91:990–1.10.1136/bjo.2007.114009
- 7. Aisenbrey S, Gelisken F, Szurman P, Bartz-Schmidt KU. Surgical treatment of peripapillary choroidal neovascularisation // Br J Ophthalmol. 2007; 91(8):1027-3010.1136/bjo.2006.108118
- 8. Singh SR, Fung AT, Fraser-Bell S et al. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation // Br J Ophthalmol, 2019; pii: bjophthalmol-2019-314542.